CTRI/2024/05/067252尚未招募3 期
An open label non comparative prospective clinical trial on the efficacyof BalRasayana syrup as an immunomodulator and its role in recurrentrespiratory tract infections in children - IMB
GURUKRUPA AMRUTA AYURVEDA LLP0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients diagnosed as suffering from Vataja Pratishyaya on Ayurvedic parameters
- •Age group of 3 to 16 years.
- •Cardinal features of recurrent respiratory tract infections
- •History of at least 3 episodes in the last six months
排除标准
- •Individuals below 3 years and above 16 years
- •Severe and Complicated respiratory allergic disorders like Bronchitis Pneumonia Tuberculosis
- •Emphysema Lung abscess Bronchiectasis
- •Patients who are diagnosed as Chronic asthma
- •Nasal polyposis
- •Congenital anomalies related to the respiratory system
- •Patients on inhaled or systemic steroids
- •Patients who are suspected of any of the diseases mentioned in exclusion criteria on the basis of history and examination will be excluded.
研究者
相似试验
尚未招募
不适用
Clinical study to evaluate the Efficacy of Nattokinase as a Nutraceutical supplement for preventing blood clot in Type II Diabetes Mellitus Patients.CTRI/2019/10/021808Dr Debananda Sahoo
已完成
不适用
Cosmetic formulation of a fairness cream in Female and Male subjects to check the fairness effectCTRI/2019/04/018629eeford Healthcare Limited India60
尚未招募
2 期
A study to compare the reduction of blood sugar,blood pressure,cholesterol and inflammatory benefits momordica charantia tablet with regular therapy in metabolic syndrome patientsCTRI/2020/06/025569Dr M Shri Vidhya
尚未招募
4 期
To evaluate the safety and efficacy of Endotone polyherbal capsule in treatment of Endometriosis.CTRI/2022/10/046666Charak Pharma Pvt Ltd
已完成
不适用
An open-label, prospective, non-comparative clinical trial to evaluate the efficacy and safety of rosuvastatin in high risk Indian population with diabetes and dyslipidemiaDiabetes patients with dyslipidemiaNutritional, Metabolic, EndocrineDyslipidemiaISRCTN22416062Ranbaxy Laboratories Ltd (India)360